相关实验视频

Updated: Jul 16, 2025

A Dual Tracer PET-MRI Protocol for the Quantitative Measure of Regional Brain Energy Substrates Uptake in the Rat

A Dual Tracer PET-MRI Protocol for the Quantitative Measure of Regional Brain Energy Substrates Uptake in the Rat

Published on: December 28, 2013

诺拉丁上腺素载体PET反映了大鼠海马中神经毒素诱导的诺拉丁上腺素水平下降

Takayuki Sakai¹, Saori Hattori¹, Aya Ogata^1,2

¹Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, Research Institute, National Center for Geriatrics and Gerontology (NCGG), Obu, Aichi, 474-8511, Japan.

EJNMMI research

|September 15, 2023

概括

对诺亚上腺素载体的正子发射断层扫描 (PET) 成像可以预测大脑的诺亚上腺素水平. 这种技术显示出作为神经退行性疾病如阿尔茨海默病 (AD) 的生物标志物具有前景.

科学领域:

神经科学是一个神经科学.
放射化学放射化学是指辐射化学.
生物标志物开发生物标志物开发

背景情况:

早期阿尔茨海默氏症 (AD) 涉及诺亚上腺素神经元的损失,影响认知功能,并可能加速疾病的进展.
降低诺亚上腺素的可用性与阿尔茨海默病的认知障碍有关.
对于诺亚上腺素神经元完整性的体内生物标志物是必要的,以了解诺亚上腺素系统在阿尔茨海默病中的作用.

研究的目的:

为了调查北上腺素载体的正子发射断层扫描 (PET) 成像是否可以预测大脑的北上腺素水平.
为了测试假设PET测量的诺亚上腺素转运体 (NET) 密度与老鼠海马中的实际诺亚上腺素度相关.

主要方法:

在老鼠身上,使用DSP-4对海马进行化学损伤,以选择性地损害noradrenergic神经元终端.
使用[11C]MRB ((S,S) -[11C]Methylreboxetine) 进行PET成像,以评估诺亚上腺素输送物密度.
尸检后的研究测量了大脑同质物中的诺亚上腺素载体和诺亚上腺素度,以验证.

主要成果:

[11C]MRB PET揭示了海马体中诺亚上腺素转运体密度的降低,这取决于DSP-4的剂量.
通过PET测量的诺亚上腺素载体密度与体外测量的诺亚上腺素度有很强的相关性.
用PET测量的输送密度也与体外输送密度有很好的相关性.

结论:

[11C]MRB PET可以作为 hippocampal noradrenaline 度在神经退行症中的体内生物标志物.
这种PET成像方法显示了未来在阿尔茨海默病研究中的应用潜力.

关键词:

脑子脑子脑子脑子在DSP-4中使用DSP.诺亚上腺素 (noradrenaline) 是一种上腺素.诺拉丁上腺素运输体的运输体定子发射断层扫描 (PET) 是一种定子发射断层扫描.鼠标鼠标鼠标鼠标 [11C]MRBB是什么意思

更多相关视频

Non-invasive Imaging and Analysis of Cerebral Ischemia in Living Rats Using Positron Emission Tomography with 18F-FDG

Non-invasive Imaging and Analysis of Cerebral Ischemia in Living Rats Using Positron Emission Tomography with 18F-FDG

Published on: December 28, 2014

Fluorescence-Activated Cell Sorting-Radioligand Treated Tissue FACS-RTT to Determine the Cellular Origin of Radioactive Signal

Fluorescence-Activated Cell Sorting-Radioligand Treated Tissue FACS-RTT to Determine the Cellular Origin of Radioactive Signal

Published on: September 10, 2021

相关概念视频

Drugs Affecting Neurotransmitter Release or Uptake

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...

Drugs Affecting Neurotransmitter Synthesis

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...